NCT02097719 - Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

bimatoprost 0.01%

Bimatoprost 0.01% administered to both eyes once daily for 12 weeks.

DRUG

travoprost 0.004%

Travoprost 0.004% administered to both eyes once daily for 12 weeks.

DRUG

timolol 0.5%

Timolol 0.5% administered to both eyes once daily for 12 weeks.

DRUG

hypromellose 0.3%

Hypromellose 0.3% lubricant eye drops (for masking purposes) administered to both eyes once daily for 12 weeks.

Trial Locations (1)

Racine